Alzheimer's Disease

For over 30 years, Lilly has been driving scientific progress in Alzheimer’s disease to improve diagnostics and innovations in science with the vision of improving outcomes for those living with the condition. 

Through ongoing clinical trials and cutting-edge research, we’re advancing the science and investigating tools to support early, accurate diagnoses and management of the condition. 

In Australia, Lilly is focused on increasing disease education across advocates, consumers, payers, providers and policymakers and working in partnership to address gaps in access to care.

Right now, we believe we have a once in a generation chance to provide people with greater treatment options in the management of Alzheimer's Disease, while also reducing the economic burden at societal level. 

PP-MG-AU-0097 04/2024